Last updated 2026-07-27
- Went public on NASDAQ (CLGN), Jan 2018
- Raised $35M Follow-on PO, Feb 2021
- Raised $5M Follow-on PO, Apr 2019
Total raised
$82.9M
Last: PIPE 2026-06
Stage
Mature
Founded
2004
Headcount
54
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The company's products are based on its proprietary plant-based genetic engineering technology to produce recombinant human collagen (rhCollagen), which is bioidentical to human collagen. This rhCollagen serves as a building block for regenerative medicine, enabling the development of products for tissue repair, aesthetics, and organ manufacturing. CollPlant's product pipeline includes regenerative breast implants, dermal fillers, and bioinks for 3D bioprinting.
Funding history · 16 rounds · $82.9M total
2026-07
Follow-on PO
$2.3M
2026-02
Follow-on PO
$2.0M
2025-07
Follow-on PO
$3.6M
2021-02
Follow-on PO
$35.0M
2019-04
Follow-on PO
$5.0M
2017-11
PIPE
$7.4M
★ Meitav Dash
2017-10
PIPE
$5.0M
★ Alpha Capital
2013-09
D Round
$2.5M
2012-10
PIPE
$2.8M
★ Meitav Dash★ Yelin Lapidot Investment House
2012-01
PIPE
$1.0M
★ Biomedix★ Docor International Management
2010-11
Follow-on PO
Undisclosed
2010-04
Reverse Merger
Undisclosed
2008-03
C Round
$8.3M
★ Docor International Management
2007-03
B Round
$4.5M
★ Docor International Management
2007-01
A Round
$2.0M
★ Modgal Industries
2006-08
Seed
$1.5M
Headcount over time
From 42 (2018-09) to 56 (2026-03) · +14 (+33%) · 45 points · source: Finder history + radar grounding
Q&A
- What is CollPlant's primary focus?
- CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing.
- What is CollPlant's proprietary technology?
- CollPlant's products are based on its proprietary plant-based genetic engineering technology to produce recombinant human collagen (rhCollagen), which is bioidentical to human collagen.
- How many employees does CollPlant currently have?
- CollPlant has 51-200 employees.
- What was the amount raised in CollPlant's Public Offering in February 2021?
- In February 2021, CollPlant raised $35,000,000 in a Public Offering.
- What was the amount raised in CollPlant's Public Offering in February 2026?
- In February 2026, CollPlant raised $2,000,000 in a Public Offering.
- What was CollPlant's most recent funding round?
- CollPlant's last funding round was a PIPE round in June 2026, which raised $2,600,000.
- When did CollPlant announce positive results from non-clinical studies of its photocurable regenerative dermal and soft tissue filler?
- CollPlant Biotechnologies announced positive results from non-clinical studies of its photocurable regenerative dermal and soft tissue filler on September 30, 2025.
- When did CollPlant expand its rhCollagen distribution capabilities in the United States and Canada?
- CollPlant expanded its rhCollagen distribution capabilities in the United States and Canada on October 27, 2025.
- When did CollPlant announce a European patent allowance for its collagen-based formulations usable as soft tissue fillers and implants?
- CollPlant Biotechnologies announced a European patent allowance for its collagen-based formulations usable as soft tissue fillers and implants on June 4, 2025.
Team · 1
Oded Shoseyov
Founder · Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenesMachinery & Robotics3D Printing & Additive Manufacturing
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
orthopedicsregenerative-medicinebiomaterialstissue-regenerationpharmaceuticalstreatmentsmedical-devicesnanotechnology3d-technologydrug-deliverymedical-productsmedical-technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | collplant.com |
|---|---|
| linkedin.com/company/2369898 | |
| facebook.com/CollPlantBio | |
| YouTube | youtube.com/channel/UC_7SlEx2hGdrw75fvVeOgsw |
Identifiers & details
| Legal name | CollPlant Biotechnologies Ltd. |
|---|---|
| Former names | CollPlant Holdings Ltd |
| Founded | 2004-8 |
| Employees (exact) | 54 |
| Offices | Yesud HaMa'ala |
| Market cap | $17.9M |
| Status reason | Public on NASDAQ on Dec 2010; |
Acquisitions & public offerings
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| IPO | 2018-01 | NASDAQ | CLGN |
Radar intelligence
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513578260 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2004-08-12 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 2 |
| Registry events | 2 — charge (2) |
| Registered address | אופנהיימר 4 רחובות |
Recent registry events
| Date | Event |
|---|---|
| 2025-10-29 | רישום שעבוד |
| 2025-10-29 | רישום שעבוד |